Press Releases
September 2023
09.05.2023
August 2023
08.30.2023
08.30.2023
08.24.2023
08.23.2023
08.21.2023
08.14.2023
08.03.2023
08.01.2023
July 2023
07.31.2023
07.27.2023
07.21.2023
Resource Library
Press Kits
These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.
View Press Kits DetailsContact Pfizer Media Relations
Media Contacts
United States, Canada, and Latin America
+1 212.733.1226
Europe, Middle East, and Africa
+44-(0)845.300.8033
Asia Pacific
+65.918.732.47
Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.
For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.
For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".
For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.
Featured Stories
The Mindfulness of Medicine Development: How Scientists Are Driving the Next Wave of Medical Innovations
For millions of patients around the world, the development of a new treatment or vaccine can be life-changing.
Bridging Global Gaps in Hemophilia Care
Pfizer is proud of its commitment to advancing hemophilia care for more than 40 years, dating back to the introduction of recombinant therapies.
The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model
About Pfizer's initiative to make clinical trials more participant-friendly through the decentralized "Clinical Trial Anywhere" model; a suite of solutions like remote sample collection, alternative study conduct locations, home health, and mobile units to reduce the need for in-person visits.